Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C

被引：0
|
作者：
Emanuele Durante-Mangoni
Antonio Parrella
Domenico Iossa
Roberto Andini
Rosa Molaro
Carminia Battimelli
Giuseppe Sodano
Riccardo Utili
机构：
[1] University of Naples S.U.N.,Internal Medicine Section, Department of Cardiothoracic Sciences
[2] Unit of Infectious and Transplant Medicine,undefined
[3] A.O.R.N. dei Colli,undefined
[4] Unit of Microbiology and Virology,undefined
[5] A.O.R.N. dei Colli,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Sofosbuvir; Sustained Viral Response; Viral Decline; Early Viral Response; Rapid Viral Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：871 / 878
页数：7
相关论文
共 50 条
  • [1] Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
    Durante-Mangoni, Emanuele
    Parrella, Antonio
    Iossa, Domenico
    Andini, Roberto
    Molaro, Rosa
    Battimelli, Carminia
    Sodano, Giuseppe
    Utili, Riccardo
    CLINICAL DRUG INVESTIGATION, 2014, 34 (12) : 871 - 878
  • [2] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [3] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis CA Meta-Analysis
    Nicolas Flori
    Natalie Funakoshi
    Yohan Duny
    Jean-Christophe Valats
    Michael Bismuth
    Dimitri Christophorou
    Jean-Pierre Daurès
    Pierre Blanc
    Drugs, 2013, 73 : 263 - 277
  • [4] Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis
    Messori, Andrea
    Fadda, Valeria
    Maratea, Dario
    Trippoli, Sabrina
    Marinai, Claudio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (02) : 246 - 248
  • [5] Antiviral potency analysis and functional comparison of consensus interferon, interferon-α2a and pegylated interferon-α2b against hepatitis C virus infection
    Erickson, Andrea K.
    Seiwert, Scott
    Gale, Michael, Jr.
    ANTIVIRAL THERAPY, 2008, 13 (07) : 851 - 862
  • [6] Treatment of chronic hepatitis delta with pegylated interferon-α2b
    Erhardt, Andreas
    Gerlich, Wolfram
    Starke, Christine
    Wend, Ulrike
    Donner, Andreas
    Sagir, Abdurrahman
    Heintges, Tobias
    Haeussinger, Dieter
    LIVER INTERNATIONAL, 2006, 26 (07) : 805 - 810
  • [7] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [8] Superiority of standard interferon-α2b compared to pegylated interferon-α2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
    Potthoff, A
    Wiegand, J
    Lüth, JB
    Wedemeyer, H
    Manns, MR
    Tillmann, HL
    CLINICAL NEPHROLOGY, 2005, 63 (03) : 232 - 235
  • [9] Impact of Conversion From Pegylated Interferon-α2b to Interferon-α2a for Treating Recurrent Hepatitis C After Liver Transplantation
    Ikegami, Toru
    Shirabe, Ken
    Yoshizumi, Tomoharu
    Furusyo, Norihiro
    Kotoh, Kazuhiro
    Kato, Masaki
    Shimoda, Shinji
    Soejima, Yuji
    Motomura, Takashi
    Fukuhara, Takasuke
    Maehara, Yoshihiko
    TRANSPLANTATION, 2013, 95 (06) : E38 - E42
  • [10] Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C
    Quinn, Davin
    Kuchler, Elizabeth
    Deming, Paulina
    Arora, Sanjeev
    PSYCHOSOMATICS, 2012, 53 (04) : 400 - 401
12345